{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T20:07:09Z","timestamp":1790885229609,"version":"4.1.0"},"reference-count":34,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,9,17]],"date-time":"2025-09-17T00:00:00Z","timestamp":1758067200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100012226","name":"Fundamental Research Funds for the Central Universities","doi-asserted-by":"publisher","award":["2022CDJYGRH-016"],"award-info":[{"award-number":["2022CDJYGRH-016"]}],"id":[{"id":"10.13039\/501100012226","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Androgenetic alopecia is the most prevalent form of progressive hair loss. Minoxidil is widely regarded as a standard treatment for this condition. Consequently, we assessed the effectiveness of minoxidil in combination with other pharmacological agents for the treatment of androgenetic alopecia.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>A comprehensive search was conducted across four databases\u2013PubMed, Embase, Web of Science, and Cochrane Library\u2013on December 10, 2024. Eligible studies were selected based on the PICOS framework. Data extraction and synthesis were carried out using a Bayesian network meta-analysis, focusing on mean difference and sample size data. League tables and Surface Under the Cumulative Ranking (SUCRA) values were employed to evaluate the relative efficacy of the interventions.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Among the 20 study groups analyzed, the combination of platelet-rich plasma and basic fibroblast growth factor with minoxidil demonstrated the highest overall efficacy (SUCRA = 93.06%). This combination resulted in a mean increase in hair density of 35.12 hairs\/cm<jats:sup>2<\/jats:sup> compared to the group treated with minoxidil alone. In male subgroups, finasteride combined with minoxidil was the most effective treatment (SUCRA = 80.18%). Among seven combination therapies for females, microneedle with minoxidil proved most effective (SUCRA = 87.18%).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>This study establishes a clinically actionable hierarchy of minoxidil-based combination therapies, providing evidence-based guidance for dermatologists to optimize androgenetic alopecia management.<\/jats:p><\/jats:sec><jats:sec><jats:title>Systematic review registration<\/jats:title><jats:p><jats:uri>https:\/\/www.crd.york.ac.uk\/PROSPERO\/view\/CRD42024623164<\/jats:uri>, identifier CRD42024623164.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fmed.2025.1638496","type":"journal-article","created":{"date-parts":[[2025,9,17]],"date-time":"2025-09-17T04:19:23Z","timestamp":1758082763000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":5,"title":["Relative efficacy of minoxidil in combination with other treatments for androgenic alopecia: a network meta-analysis based on randomized controlled trials"],"prefix":"10.3389","volume":"12","author":[{"given":"Yinfeng","family":"Xia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongsong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiyong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,9,17]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1001\/jamadermatol.2021.2196","article-title":"Health-related quality of life, depression, and self-esteem in patients with androgenetic alopecia: a systematic review and meta-analysis.","volume":"157","author":"Huang","year":"2021","journal-title":"JAMA Dermatol."},{"key":"B2","first-page":"15","article-title":"Androgenetic alopecia.","volume":"149","author":"Piraccini","year":"2014","journal-title":"G Ital Dermatol Venereol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1046\/j.1523-1747.2003.12168.x","article-title":"Androgenetic alopecia in women.","volume":"8","author":"Price","year":"2003","journal-title":"J Investig Dermatol Symp Proc."},{"key":"B4","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1007\/s40265-023-01880-x","article-title":"Androgenetic alopecia: therapy update.","volume":"83","author":"Devjani","year":"2023","journal-title":"Drugs."},{"key":"B5","doi-asserted-by":"publisher","first-page":"3759","DOI":"10.1111\/jocd.14537","article-title":"Treatment options for androgenetic alopecia: efficacy, side effects, compliance, financial considerations, and ethics.","volume":"20","author":"Nestor","year":"2021","journal-title":"J Cosmet Dermatol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"2867","DOI":"10.1111\/jocd.13976","article-title":"Pumpkin seed oil vs. minoxidil 5% topical foam for the treatment of female pattern hair loss: a randomized comparative trial.","volume":"20","author":"Ibrahim","year":"2021","journal-title":"J Cosmet Dermatol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"6516","DOI":"10.3390\/ijms21186516","article-title":"Comparative evaluation of the clinical efficacy of PRP-therapy, minoxidil, and their combination with immunohistochemical study of the dynamics of cell proliferation in the treatment of men with androgenetic alopecia.","volume":"21","author":"Pakhomova","year":"2020","journal-title":"Int J Mol Sci."},{"key":"B8","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1111\/dth.12246","article-title":"Combined treatment with oral finasteride and topical minoxidil in male androgenetic alopecia: a randomized and comparative study in Chinese patients.","volume":"28","author":"Hu","year":"2015","journal-title":"Dermatol Ther."},{"key":"B9","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1111\/ced.13551","article-title":"A pilot split-scalp study of combined fractional radiofrequency microneedling and 5% topical minoxidil in treating male pattern hair loss.","volume":"43","author":"Yu","year":"2018","journal-title":"Clin Exp Dermatol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"e14678","DOI":"10.1111\/dth.14678","article-title":"A novel topical combination of minoxidil and spironolactone for androgenetic alopecia: clinical, histopathological, and physicochemical study.","volume":"34","author":"Abdel-Raouf","year":"2021","journal-title":"Dermatol Ther."},{"key":"B11","doi-asserted-by":"publisher","first-page":"777","DOI":"10.7326\/M14-2385","article-title":"The PRISMA extension statement for reporting of systematic reviews incorporating network meta-analyses of health care interventions: checklist and explanations.","volume":"162","author":"Hutton","year":"2015","journal-title":"Ann Intern Med."},{"key":"B12","doi-asserted-by":"publisher","first-page":"547","DOI":"10.4103\/ijdvl.IJDVL_1156_16","article-title":"The effectiveness of adding low-level light therapy to minoxidil 5% solution in the treatment of patients with androgenetic alopecia.","volume":"84","author":"Faghihi","year":"2018","journal-title":"Indian J Dermatol Venereol Leprol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1002\/lsm.23411","article-title":"Efficacy of minoxidil combined with photobiomodulation for the treatment of male androgenetic alopecia. a double-blind half-head controlled trial.","volume":"53","author":"Ferrara","year":"2021","journal-title":"Lasers Surg Med."},{"key":"B14","doi-asserted-by":"publisher","first-page":"103966","DOI":"10.1016\/j.pdpdt.2024.103966","article-title":"Comparative efficacy of 2% minoxidil alone against combination of 2% minoxidil and low-level laser therapy in female pattern hair loss-A randomized controlled trial in Chinese females.","volume":"45","author":"Yang","year":"2024","journal-title":"Photodiagnosis Photodyn Ther."},{"key":"B15","doi-asserted-by":"publisher","first-page":"1857","DOI":"10.1007\/s10103-019-02783-8","article-title":"A randomized, investigator-blinded, controlled, split-scalp study of the efficacy and safety of a 1550-nm fractional erbium-glass laser, used in combination with topical 5% minoxidil versus 5% minoxidil alone, for the treatment of androgenetic alopecia.","volume":"34","author":"Suchonwanit","year":"2019","journal-title":"Lasers Med Sci."},{"key":"B16","doi-asserted-by":"publisher","first-page":"1738","DOI":"10.1111\/jocd.13228","article-title":"Accelerated hair growth by combining thread monofilament and minoxidil in female androgenetic alopecia.","volume":"19","author":"Khattab","year":"2020","journal-title":"J Cosmet Dermatol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"150","DOI":"10.4103\/ijdvl.IJDVL_589_18","article-title":"Comparison of efficacy of platelet-rich plasma therapy with or without topical 5% minoxidil in male-type baldness: a randomized, double-blind placebo control trial.","volume":"86","author":"Singh","year":"2020","journal-title":"Indian J Dermatol Venereol Leprol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1097\/DSS.0000000000001198","article-title":"Platelet-rich plasma in combination with 5% minoxidil topical solution and 1 mg oral finasteride for the treatment of androgenetic alopecia: a randomized placebo-controlled, double-blind, half-head study.","volume":"44","author":"Alves","year":"2018","journal-title":"Dermatol Surg."},{"key":"B19","doi-asserted-by":"publisher","first-page":"1995","DOI":"10.1111\/jocd.15825","article-title":"Evaluation of platelet-rich plasma plus basic fibroblast growth factor combined with minoxidil in the treatment of androgenetic alopecia: a randomized controlled trial.","volume":"22","author":"Wu","year":"2023","journal-title":"J Cosmet Dermatol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/14764172.2017.1376094","article-title":"Randomized trial of electrodynamic microneedle combined with 5% minoxidil topical solution for the treatment of Chinese male Androgenetic alopecia.","volume":"22","author":"Bao","year":"2020","journal-title":"J Cosmet Laser Ther."},{"key":"B21","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1080\/09546634.2020.1770162","article-title":"Randomized trial of electrodynamic microneedling combined with 5% minoxidil topical solution for treating androgenetic alopecia in Chinese males and molecular mechanistic study of the involvement of the Wnt\/\u03b2-catenin signaling pathway.","volume":"33","author":"Bao","year":"2022","journal-title":"J Dermatolog Treat."},{"key":"B22","doi-asserted-by":"publisher","first-page":"6985","DOI":"10.1111\/jocd.15424","article-title":"Randomized trial of microneedling combined with 2% minoxidil topical solution for the treatment of female pattern hair loss in a Chinese population.","volume":"21","author":"Zhang","year":"2022","journal-title":"J Cosmet Dermatol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"905140","DOI":"10.3389\/fmed.2022.905140","article-title":"Efficacy and safety of 5% minoxidil alone, minoxidil plus oral spironolactone, and minoxidil plus microneedling on female pattern hair loss: a prospective, single-center, parallel-group, evaluator blinded, randomized trial.","volume":"9","author":"Liang","year":"2022","journal-title":"Front Med."},{"key":"B24","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1007\/s40257-018-0387-0","article-title":"Efficacy of topical combination of 0.25% finasteride and 3% minoxidil versus 3% minoxidil solution in female pattern hair loss: a randomized, double-blind, controlled study.","volume":"20","author":"Suchonwanit","year":"2019","journal-title":"Am J Clin Dermatol."},{"key":"B25","doi-asserted-by":"publisher","first-page":"2257","DOI":"10.1111\/jdv.15171","article-title":"randomized, double-blind controlled study of the efficacy and safety of topical solution of 0.25% finasteride admixed with 3% minoxidil vs. 3% minoxidil solution in the treatment of male androgenetic alopecia.","volume":"32","author":"Suchonwanit","year":"2018","journal-title":"J Eur Acad Dermatol Venereol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1111\/jocd.15953","article-title":"Efficacy of the association of topical minoxidil and topical finasteride compared to their use in monotherapy in men with androgenetic alopecia: a prospective, randomized, controlled, assessor blinded, 3-arm, pilot trial.","volume":"23","author":"Rossi","year":"2024","journal-title":"J Cosmet Dermatol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"4447","DOI":"10.1111\/jocd.14788","article-title":"Comparison between \u201c5% minoxidil plus 2% flutamide\u201d solution vs. \u201c5% minoxidil\u201d solution in the treatment of androgenetic alopecia.","volume":"21","author":"Faghihi","year":"2022","journal-title":"J Cosmet Dermatol."},{"key":"B28","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1007\/s00403-022-02512-2","article-title":"Comparison between topical cetirizine with minoxidil versus topical placebo with minoxidil in female androgenetic alopecia: a randomized, double-blind, placebo-controlled study.","volume":"315","author":"Bassiouny","year":"2023","journal-title":"Arch Dermatol Res."},{"key":"B29","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1089\/fpsam.2020.0288","article-title":"Autologous concentrated growth factors combined with topical minoxidil for the treatment of male androgenetic alopecia: a randomized controlled clinical trial.","volume":"23","author":"Tan","year":"2021","journal-title":"Facial Plast Surg Aesthet Med."},{"key":"B30","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1046\/j.1365-2133.1999.03030.x","article-title":"The psychosocial consequences of androgenetic alopecia: a review of the research literature.","volume":"141","author":"Cash","year":"1999","journal-title":"Br J Dermatol."},{"key":"B31","doi-asserted-by":"publisher","first-page":"e15262","DOI":"10.1111\/dth.15262","article-title":"Efficacy comparison of monotherapies and combination therapies for androgenetic alopecia: a Bayesian network meta-analysis.","volume":"35","author":"Chen","year":"2022","journal-title":"Dermatol Ther."},{"key":"B32","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1159\/000534196","article-title":"Relative effects of minoxidil 5%, platelet-rich plasma, and microneedling in pattern hair loss: a systematic review and network meta-analysis.","volume":"9","author":"Gupta","year":"2023","journal-title":"Skin Appendage Disord."},{"key":"B33","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1007\/s40257-022-00730-y","article-title":"What\u2019s new in therapy for male androgenetic alopecia?","volume":"24","author":"Saceda-Corralo","year":"2023","journal-title":"Am J Clin Dermatol."},{"key":"B34","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1007\/s40257-014-0077-5","article-title":"Androgenetic alopecia: an evidence-based treatment update.","volume":"15","author":"Varothai","year":"2014","journal-title":"Am J Clin Dermatol."}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2025.1638496\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,17]],"date-time":"2025-09-17T04:19:24Z","timestamp":1758082764000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2025.1638496\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,17]]},"references-count":34,"alternative-id":["10.3389\/fmed.2025.1638496"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2025.1638496","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,17]]},"article-number":"1638496"}}